These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31562917)

  • 1. Neuroprotective effects of docosahexaenoic acid against sub-acute manganese intoxication induced dopaminergic and motor disorders in mice.
    El Fari R; Abbaoui A; Bourziq A; Zroudi M; Draoui A; El Khiat A; Belkouch M; Elgot A; Gamrani H
    J Chem Neuroanat; 2019 Dec; 102():101686. PubMed ID: 31562917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease.
    Abbaoui A; Chatoui H; El Hiba O; Gamrani H
    Neurosci Lett; 2017 Nov; 660():103-108. PubMed ID: 28919537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson's disease.
    Hacioglu G; Seval-Celik Y; Tanriover G; Ozsoy O; Saka-Topcuoglu E; Balkan S; Agar A
    Folia Histochem Cytobiol; 2012 Jul; 50(2):228-38. PubMed ID: 22763967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum.
    Chitre NM; Wood BJ; Ray A; Moniri NH; Murnane KS
    Neuropharmacology; 2020 May; 167():107976. PubMed ID: 32001239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective potential of Aloe arborescens against copper induced neurobehavioral features of Parkinson's disease in rat.
    Abbaoui A; Hiba OE; Gamrani H
    Acta Histochem; 2017 Jun; 119(5):592-601. PubMed ID: 28619286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate and sodium butyrate attenuate manganese-decreased locomotor activity and astrocytic glutamate transporters expression in mice.
    Johnson J; Pajarillo EAB; Taka E; Reams R; Son DS; Aschner M; Lee E
    Neurotoxicology; 2018 Jan; 64():230-239. PubMed ID: 28610743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese-exposed developing rats display motor deficits and striatal oxidative stress that are reversed by Trolox.
    Cordova FM; Aguiar AS; Peres TV; Lopes MW; Gonçalves FM; Pedro DZ; Lopes SC; Pilati C; Prediger RD; Farina M; Erikson KM; Aschner M; Leal RB
    Arch Toxicol; 2013 Jul; 87(7):1231-44. PubMed ID: 23385959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
    Rai SN; Yadav SK; Singh D; Singh SP
    J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.
    Langley MR; Ghaisas S; Ay M; Luo J; Palanisamy BN; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Neurotoxicology; 2018 Jan; 64():240-255. PubMed ID: 28595911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal nitric oxide synthase phosphorylation induced by docosahexaenoic acid protects dopaminergic neurons in an experimental model of Parkinson's disease.
    Parlak H; Ozkan A; Dilmac S; Tanriover G; Ozsoy O; Agar A
    Folia Histochem Cytobiol; 2018; 56(1):27-37. PubMed ID: 29577226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrastriatal manganese chloride exposure causes acute locomotor impairment as well as partial activation of substantia nigra GABAergic neurons.
    Yang Y; An J; Wang Y; Luo W; Wang W; Mei X; Wu S; Chen J
    Environ Toxicol Pharmacol; 2011 Jan; 31(1):171-8. PubMed ID: 21787683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
    Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
    Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructure lipid carriers enhance alpha-mangostin neuroprotective efficacy in mice with rotenone-induced neurodegeneration.
    Sakamula R; Yata T; Thong-Asa W
    Metab Brain Dis; 2022 Jun; 37(5):1465-1476. PubMed ID: 35353275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total glucosides of paeony (TGP) extracted from Radix Paeoniae Alba exerts neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the cAMP/PKA/CREB signaling pathway.
    Zheng M; Liu C; Fan Y; Shi D; Jian W
    J Ethnopharmacol; 2019 Dec; 245():112182. PubMed ID: 31445131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson's disease therapy.
    Zaitone SA; Ahmed E; Elsherbiny NM; Mehanna ET; El-Kherbetawy MK; ElSayed MH; Alshareef DM; Moustafa YM
    Pharmacol Rep; 2019 Feb; 71(1):32-41. PubMed ID: 30368226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
    J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta.
    Cankara FN; Günaydın C; Bilge SS; Özmen Ö; Kortholt A
    Neurosci Lett; 2020 Nov; 738():135308. PubMed ID: 32932183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.